Detection Technology (DETEC) Q2 2025 earnings summary

Executive summary

• Q2 2025 net sales declined 6.6% year-over-year to €24.4 million, with EBITDA/EBITA margin dropping to 7% from 12.7% last year.

• H1 2025 net sales fell 4.5% year-over-year to €46.6 million, with EBITDA/EBITA margin at 6.7% versus 11.4% last year.

• Market position remained solid despite sales decline, mainly due to halted security CT installations, regulatory delays, and currency headwinds.

• Medical and industrial applications showed growth, while security and EMEIA region experienced sharp declines.

• Strategic launches in flat panel detectors and expansion in India supported long-term growth initiatives.

Financial highlights

• Q2 2025 EBITA was €1.7 million, down from €3.3 million in Q2 2024; H1 EBITA was €3.1 million, down from €5.6 million.

• Q2 earnings per share: €0.07 (prior year €0.15); H1 EPS: €0.11 (prior year €0.26).

• Cash flow from operations in H1: €1.9 million (prior year €6.8 million); cash and cash equivalents at period end: €20.2 million.

• Investments in H1: €1.5 million, focused on R&D and production equipment.

• Dividend of €7.3 million paid in H1 2025.

Outlook and guidance

• Single-digit year-on-year net sales decline expected in Q3 and H2 2025, mainly due to forex headwinds and supply chain issues.

• Industrial segment expected to grow in Q3, while medical and security are forecasted to decline.

• Americas region anticipated to see a double-digit decline in Q3; APAC and EMEIA expected to remain stable.

• Recovery in security segment anticipated to start late Q4 or next year as European regulatory changes take effect.

• Medium-term targets: annual sales growth of at least 10%, EBITA margin of 15%, and 30–60% dividend/return of capital.